1.0 OBJECTIVE: Cleaning Validation Protocol for Multi Mill is designed to ensure that the cleaning procedure for multi mill removes residues to the extent of compliance with pre-determined acceptance level.
2.0 SCOPE: This protocol applies to Pharmaceutical Manufacturing Facility.
3.0 RESPONSIBILITY: It is a joint responsibility of Quality Control, Production, and Quality Assurance departments. The detailed responsibility is given below
- Protocol Preparation – Executive QA
- Protocol Approval – Head – QA
- Protocol Execution – Head – Production
- Sampling as per Protocol – Executive – QA
- Testing as per Protocol – Executive – QC
- Test Results Review and Approval – Manager – QC
- Validation Data Compilation – Executive – QA
- Validation Final Approval – Head – QA
4.0 PROCEDURE: for Cleaning Validation Protocol for Multi-mill
- Clean the equipment as per SOP (Title: Procedure for cleaning of Multi Mill)
- Sample from the specified sampling points. Refer below ( 6.0) as per the sampling plan (5.0).
5.0 SAMPLING PLAN
- First, wash with Raw Water, and then Sample from first rinse (sample-I).
- For second sample, wash with 0.1% liquid soap solution and raw water, then sample from second rinse (sample-II).
- Sample from final rinse of purified water after completion of the cleaning procedure (sample-III).
- Swab (in 2.5 cm x 2.5 cm area) for chemical analysis (sample-IV).
- Swab (in 10 cm x 10 cm area) for bio-burden (sample-V).
6.0 SAMPLING POINTS
- Powder Feed Hopper
- Blades
- Screen
- Powder discharge Hopper.
Please refer ANNEXURE – B
7.0 TEST / METHOD
- Inspect visually for the absence of previous product in the equipment from (sample-I)
- Determine the absence of detergents by froth method from (sample-II ).
- Determine the concentration of active ingredient of the previous product in the final rinse from (sample III).
- Determine the concentration of active ingredient of the previous product in the swab from (sample IV).
- Report and record the above test (1,2,3 and 4) results in ANNEXURE – C
- Determine the bio-burden from (sample V) and record the results in ANNEXURE– D
8.0 ACCEPTANCE CRITERIA
- No traces of the powder shall be visible on any part of the machine (sample-I)
- Detergent should not be identifiable by frothing test (sample-II ).
- Concentration of the previous product should not be more than 10 PPM in the final rinse i.e., (sample III)
- Concentration of the previous product should not be more than 2 PPM in the swab (i.e., sample IV)
- Bio-burden limits are as below (sample V)
- Total CFU – NMT 10 CFU
- E. Coli -absent
- Salmonella – absent
9.0 ANNEXURE – A

10.0 ANNEXURE – B

11.0 ANNEXURE-C

12.0 ANNEXURE-D


Naresh Bhakar is the Founder and Author at Pharmaguddu.com, bringing his extensive expertise in the field of pharmaceuticals to readers worldwide. He has experience in Pharma manufacturing and has worked with top Pharmaceuticals. He has rich knowledge and provides valuable insights and data through his articles and content on Pharmaguddu.com. For further inquiries or collaborations, please don’t hesitate to reach out via email at [email protected].